In a report released yesterday, Jailendra Singh from Truist Financial maintained a Hold rating on Cano Health (CANO – Research Report). The company’s shares closed yesterday at $1.45.
Singh covers the Healthcare sector, focusing on stocks such as Cano Health, CareMax, and IQVIA Holdings. According to TipRanks, Singh has an average return of -12.9% and a 36.69% success rate on recommended stocks.
Currently, the analyst consensus on Cano Health is a Hold with an average price target of $2.19.
See the top stocks recommended by analysts >>
CANO market cap is currently $797.6M and has a P/E ratio of -1.47.
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CANO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Jaws Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Read More on CANO:
- Investor group with 35% stake in Cano ‘condemn Board’s egregious conduct’
- Cano Health holders Cooperstone, Gold, Sternlicht address leadership transition
- Cano Health Gains on Top Rung Shakeup
- Cano Health CEO Marlow Hernandez to resign, Mark Kent named interim CEO
- Cano Health reports company’s two director nominees re-elected
